How to Buy Champions Oncology Stock
Champions Oncology Inc
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.
Champions Oncology stock last closed at $7.97, down 4.09% from the previous day, and has increased 58.45% in one year. It has overperformed other stocks in the Biotechnology industry by 1.37 percentage points. Champions Oncology stock is currently +121.39% from its 52-week low of $3.60, and -33.53% from its 52-week high of $11.99.
At the moment, there are 13.83M shares of CSBR outstanding. The market cap of CSBR is $110.20M. In the last 24 hours, 25,876 CSBR shares were traded.
How to Buy Champions Oncology Stock
Wondering how to invest in Champions Oncology stock? Here's how.
- Choose where to buy Champions Oncology stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Champions Oncology stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Choose your method of payment and add your details.
- Research Champions Oncology stock: The Champions Oncology ticker symbol is CSBR. Is Champions Oncology stock a good investment? Should you buy shares of CSBR? How do CSBR's underlying business fundamentals look? Do top analysts think Champions Oncology is a good buy? Why has CSBR's stock price moved recently? (Hint: Our stock market research tools can help you decide if CSBR is a good stock to buy).
- Execute your CSBR trade: Decide if you will purchase CSBR shares at the current market price or use a limit order to buy CSBR stock at a specific price.
- Get updates on your investment in CSBR: Create a watchlist to track your investment in Champions Oncology shares.
Step 1: Choose where to buy Champions Oncology stock
You need an online brokerage account in order to access the NASDAQ market and buy CSBR stock.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to buy CSBR today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on one of the most highly reviewed stock trading apps, you can securely and quickly fund your account:
Check out the video below for more details depositing funds into your new brokerage account.
Step 4: Research Champions Oncology stock
Once you have identified the best place to buy Champions Oncology stock, it's absolutely critical to analyze their stock before you invest, so you actually understand the risk and opportunity.
Overview of key CSBR info
CSBR Due Diligence Score
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CSBR's stock page.
Is CSBR stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge CSBR's fair value.
Using relative valuations metrics:
- CSBR could be undervalued based on its P/E ratio of 16.96x, relative to Biotechnology industry P/E ratio of -177.72x
- CSBR may be overvalued based on its P/B ratio of 20.15x, relative to Biotechnology industry P/B ratio of 4.05x
- CSBR may be undervalued based on its PEG ratio of 0.08x
You can do additional valuation analysis on CSBR's stock here.
A quick look at CSBR Financials
Signs that CSBR is financially healthy:
- CSBR profit margin has gone up from -19.8% to 11% in the past year.
- CSBR has $3.20M in cash and short term investments. This is enough to cover its annual cash burn of $1.32M.
- There are more short-term assets than long-term liabilities on the CSBR balance sheet.
- CSBR has cash burn of 1323000. It has sufficient cash and short-term investments to cover this for at least one year.
Signs that CSBR is not financially healthy:
- Total CSBR debt is higher than 5 years ago, relative to shareholder equity.
- There are more short-term liabilities than short-term assets on the CSBR balance sheet.
- CSBR has a relatively high debt to equity ratio of 4.6.
Do Wall Street analysts think it's a good time to buy Champions Oncology stock
Out of 1 Wall Street analysts who give ratings on CSBR, the consensus analyst rating on CSBR is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Champions Oncology stock forecast page.
CSBR Technicals
CSBR Performance Metrics
Last year, CSBR earnings were $6.43M. During the past three year, CSBR's earnings have gone up by 282.31% per year. This was faster than the Biotechnology industry average of 10.71%.
Last year, CSBR revenue was $58.59M. Over the last 5 year, CSBR's revenue has gone up by 13.51% per year. This was slower than the Biotechnology industry average of 44.43%.
Dive into CSBR's earnings and revenue performance here.
Who is buying/selling CSBR?
In the last year, insiders at CSBR have bought more shares than they have sold.
Joel Ackerman, Director of CSBR, was the latest CSBR insider to buy. They bought $90,501.81 worth of CSBR shares on Oct 31, 2024.
Research more about who owns CSBR stock here.
Does CSBR stock generate passive income?
No, Champions Oncology doesn't provide an income stream by paying out dividends.
CSBR Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CSBR trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, use a limit order.
Click the Open button and eToro will place the order.
If you want more assistance buying stocks on eToro, click the how to video below:
Step 6: Get updates on your investment in CSBR
Now that you own some CSBR stock, you'll want to stay up-to-date on your new company.
Start a watchlist to get notified of important updates regarding your CSBR stock.
CSBR Feed
How to Buy Stock in Champions Oncology
To reiterate, here are the 6 steps to buy Champions Oncology stock:
- Choose where to buy Champions Oncology stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Research Champions Oncology stock
- Execute your CSBR trade
- Get updates on your investment in CSBR
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your investment in Champions Oncology, add CSBR to your watchlist by clicking the button below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.